Cross-sectional study of clinical distinctions between neuropathic and inflammatory pruritus - 10/11/18
Doi : 10.1016/j.jaad.2018.05.1236
Jordan Daniel Rosen, BS a, b, Anna Chiara Fostini, MD a, b, c, Yoing Huak Chan, PhD d, Leigh Ann Nattkemper, PhD a, b, Gil Yosipovitch, MD a, b, ⁎ 
a Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
b Miami Itch Center, University of Miami Miller School of Medicine, Miami, Florida
c Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy
d Biostatistic Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
∗Correspondence to: Gil Yosipovitch, MD, 1475 NW 1st Ave, Miami, FL 331361475 NW 1st AveMiamiFL33136
| Funding sources: None. |
|
| Conflicts of interest: Dr Yosipovitch is a member of the scientific advisory boards and consults for Trevi, Menlo, Opko, Sienna, Sanofi, Eli Lilly, Galderma, Novartis, and Pfizer. He is a principal investigator for and funded by Sun Pharma, Pfizer, Menlo, Kinska, and Vanda. The remaining authors have no conflicts of interest to disclosed. |
|
| Reprints not available from the authors. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 6
P. 1143-1144 - décembre 2018 Retour au numéro
Article précédent
- Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials
- Alexandra B. Kimball, Murali Sundaram, Alan L. Shields, Stacie Hudgens, Martin Okun, Catherine Foley, Arijit Ganguli
- A cohort study of risk factors, clinical presentations, and outcomes for dermatophyte, nondermatophyte, and mixed toenail infections
- Nuntida Salakshna, Sumanas Bunyaratavej, Lalita Matthapan, Kamonpan Lertrujiwanit, Charussri Leeyaphan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?